#United States #New York #Class Action #Pomerantz LLP #SelectQuote

Investor Alert: Class Action Lawsuit Against SelectQuote, Inc.

The Pomerantz Law Firm has recently announced a class action lawsuit against SelectQuote, Inc. (NYSE: SLQT), indicating a potential opportunity for investors who have recently faced losses due to the company's alleged misconduct. This alert serves to inform affected investors of critical timelines as they consider their next steps in potentially joining the litigation.

Key Details of the Lawsuit

The lawsuit primarily addresses serious allegations against SelectQuote regarding securities fraud and other unlawful business practices. According to the claims, SelectQuote and certain officers or directors are accused of engaging in fraudulent activities that misled investors. The firm’s actions purportedly led to significant damages for investors, including a drastic drop in stock price following disclosure of these allegations.

What Happened?

On May 1, 2025, the U.S. Department of Justice (DOJ) filed a complaint under the False Claims Act against SelectQuote. The DOJ alleges that from 2016 through at least 2021, SelectQuote received millions in illegal kickbacks from health insurance companies for steering Medicare beneficiaries towards specific insurers' plans. This practice raises serious ethical and legal questions, indicating blatant discrimination against beneficiaries deemed less profitable, including individuals with disabilities.

The DOJ has also claimed that SelectQuote falsely advertised their services, stating they offered unbiased coverage comparisons. In reality, they primarily directed beneficiaries towards insurers who compensated them the most, regardless of the quality of service provided. Following the DOJ's announcement, SelectQuote's stock value plummeted 19.24%, reflecting investors' lost confidence in the company's practices.

Investor Actions

Investors who believe they have suffered losses due to SelectQuote’s alleged actions are strongly encouraged to take note of upcoming deadlines related to this class action lawsuit. Specifically, individuals who purchased SelectQuote securities during the class period can seek appointment as Lead Plaintiff in court until October 10, 2025. Interested parties can get further details about this process at the Pomerantz Law Firm’s website.

For those wishing to connect with the suit, Danielle Peyton from Pomerantz LLP can be reached via email at [email protected] or by phone at 646-581-9980, with toll-free options available.

The Role of Pomerantz LLP

Pomerantz LLP is recognized as one of the leading firms engaging in corporate, securities, and antitrust class litigation. Established by Abraham L. Pomerantz, known as a pioneer in this field, the firm has over 85 years of experience advocating for investors. Their extensive history includes securing multimillion-dollar awards on behalf of class members who have fallen victim to corporate misconduct.

Interested investors can find more information about their rights and the steps they can take to join this class action by visiting www.pomlaw.com.

Conclusion

As the investigation continues, it's crucial for investors affected by SelectQuote's allegations to stay informed and ready to act. Timely engagement with legal counsel can help protect their rights and possibly recover losses incurred during this turbulent period. The forthcoming weeks will prove critical for those seeking justice and accountability in the face of these serious allegations against SelectQuote, Inc.